Shared by 
Unlock all 11 pages
Get it free by sharing your own notes, buy just this one, or become a member and unlock documents with your plan.
How to unlock this document
Choose the way that suits you. Each one gives you all 11 pages to read online and the PDF to download.
Share your notes, unlock for free
2 free unlocks for every 5 approved uploads
- Upload your own lecture notes, assignments, essays or past papers
- PDF, Word, PowerPoint and Excel files all work, and you can send many at once
- We check each upload; you get a notification when it is approved
- Spend a free unlock on this document or any other, and keep it for good
- Shared under your public username, never your email
Then upload your notes from your profile.
Buy this document
$11 one-time payment
- All 11 pages of this document, yours to keep
- Download the PDF and read it any time, also offline
- No subscription and nothing to cancel
- Find it again any time under My Profile → Library
You log in or create a free account first, then pay securely.
Become a member
Unlock documents from the whole library, which keeps growing
- Choose any documents you like, up to your plan’s unlocks
- Documents you unlock stay yours, even if you cancel later
- Your unlocks start again with every renewal
- Secure checkout by Dodo Payments
You log in or create a free account first, then pay securely.
Compare the plansAlready a member, or bought this before? Log in to open it
About this document
- Pages
- 11 pages
- Price
- $11 one-time, yours to keep
- Membership
- Included in every plan
- Format
- Subject
- Business, Marketing
This case study covers the launch strategy for Datril, a new non-prescription acetaminophen drug. It discusses the challenges and options for positioning, pricing, and promoting Datril in the market. It is useful for understanding business strategy and marketing decisions.
What's inside
- Background on Datril and the market
- Problem recognition and challenges
- Option listing for positioning, pricing, and promoting
- Recommendations for Datril's success
- Analysis of customer value, competitive advantage, and company value
Who it is for: Students studying business strategy and marketing. (Postgraduate)
Share with classmates: WhatsApp Telegram X LinkedIn Facebook
Summary
Datril is a non-prescription acetaminophen drug. Students learn about marketing and business strategy. This case study looks at Datril's launch in 1975.
Bristol-Myers' Problems
Bristol-Myers is planning to launch Datril. They need to decide how to position, price and promote it. They need to consider the impact on their other brands.
Market Growth Strategy
Bristol-Myers can attract aspirin users to Datril. This could benefit Tylenol, but hurt Bristol-Myers' own aspirin brands. Datril can target a $680 million market.
Datril's Value Proposition
Datril offers pain relief without anti-inflammatory effects. It is cheaper than Tylenol. Students consider how to communicate this to customers.
Competitive Strategy
Datril's benefits are similar to Tylenol. It has competitive strength through Bristol-Myers' brand recognition. Students consider how to gain market share.
Key terms
- test market
- A small-scale market to test Datril's performance.
- reference pricing
- Pricing Datril based on Tylenol's price.
- penetration pricing
- Lowering Datril's price to gain market share.
- primary demand switch
- Shifting consumers from aspirin to acetaminophen.
- Bristol-Myers
- The company planning to launch Datril.
- Tylenol
- The only other acetaminophen-based drug.
Questions this document helps with
- How should Datril be positioned in the market?
- What price should Datril be sold at?
- How should Datril be promoted to consumers?
Summary written with AI from the document's text.
Ask the AI Teacher
Ask any question about this document or your course, and get a clear explanation.
Log in to ask Create a free account
Free accounts can ask 5 questions a day.